Procoagulant and anticoagulant mechanisms in human placenta.
Procoagulant expression in platelets and defects leading to clinical disorders.
Procoagulant stress reactivity and recovery in apparently healthy men with systolic and diastolic hypertension.
John's Wort Decreased effect Stimulation of cytochrome 2C9, which is responsible for metabolizing a major warfarin racemate Acerola/Vitamin C Antagonistic effect Excessive amounts of vitamin C associated with a
procoagulant effect Fish Oils Synergistic effect Presumably through a decrease in platelet aggregation * Condensed from Natural Medicines Comprehensive Database, 2001 Table 4.
Its powerful activity is linked to the presence of a pentasaccharidic sequence which catalyses the activity of circulating inhibitors of the
procoagulant enzymatic sites generated during the activation of the coagulation system, resulting for instance in a fast neutralization of thrombin.
The owners of the Angio-Seal product have now brought patent infringement lawsuits against all three of their competitors in vascular sealing, whether the device is a suture, a collagen plug or a flowable
procoagulant. Patients and patient care would benefit if these resources were re-directed into developing new and better devices," Mr.
Circulating estrogens induce the hepatic production of
procoagulant factors VII, VIII, IX, and X.
This new formulation is manufactured using a caprylate chromatography process, which significantly reduces
procoagulant activity and product impurities such as IgG aggregates.
In conjunction, the company's new formulation is manufactured using a sophisticated caprylate chromatography process, which reduces
procoagulant activity and product impurities.
[7]
Procoagulant activity has been shown to be associated with stage of the disease.
Our results are consistent with a previous study conducted by EwaStepien et al.3 They specifically observed that tissue-factor bearing PDMPs (CD42/CD142) were increased in patients of AMI, suggesting
procoagulant state in AMI.
Circulating
procoagulant microparticles (MPs) are small membrane vesicles that are derived from different cells (e.g., platelets, endothelial cells, leukocytes, lymphocytes, and erythrocytes) in response to activation, injury, and/or apoptosis [47].
